Sunday, February 9, 2025
wellness India Expo
Home Editor’s Zone

Editor’s Zone

This space is for the Editor’s critical take on the various issues of importance that have happened during the week. The inside review of various initiatives, developments and the news that mattered most. Few a times, its a bitter pill yet next time a sweet candy, the ‘Editor’s Zone’ acts as an applauder, neutral observer and critic depending on the objectivity.

Feel free to connect with the Editor at rk@biovoicenews.com

Face to Face

FACE TO FACE: Harish Bisam, Founder & MD, Bisam Pharmaceuticals

168
Harish Bisam, Founder & Managing Director, Bisam Pharmaceuticals shares insights on his company’s trademark, Quick Vitals, the world's first AI and deep learning powered health monitoring app

Chat with BioVoice

“Our mission is to build self-reliance in antibody development & manufacturing”

34
In an exclusive interview, Supriya Kashikar, Founder & CEO, GeNext Genomics shares her insights on the company’s current operations, collaboration with Merck and long-term goals

R&D

Events